Table 2.
The affinity of the putative compounds with core targets.
| Compound | Affinity -TP53 (kcal/mol) | Affinity-FN1 (kcal/mol) | Affinity-ESR1 (kcal/mol) | Affinity-CDK2 (kcal/mol) | Affinity -HSPA5 (kcal/mol) |
|---|---|---|---|---|---|
| Dehydrotanshinone II A | −7.6 | −4.0 | −8.7 | −11.5 | −8.3 |
| 3β-acetoxyatractylone | −6.8 | −3.3 | −8.7 | −8.6 | −6.9 |
| baicalein | −6.6 | −4.0 | −8.4 | −8.7 | −9.7 |
| kaempferol | −6.4 | −3.9 | −8.3 | −8.4 | −8.8 |
| wogonin | −6.9 | −3.9 | −8.3 | −8.7 | −7.9 |
| quercetin | −6.5 | −3.9 | −8.1 | −8.8 | −8.2 |
| Phellopterin | −6.6 | −3.4 | −7.9 | −8.5 | −7.0 |
| phellamurin_qt | −7.4 | −3.8 | −7.2 | −9.4 | −7.8 |
| Mandenol | −4.3 | −1.6 | −7.1 | −6.4 | −4.2 |
| rutaecarpine | −8.3 | −4.2 | −7.0 | −10.5 | −9.6 |
| 2-Monoolein | −4.9 | −2.1 | −6.6 | −6.5 | −4.7 |
| Spinasterol | −7.9 | −3.8 | −6.5 | −9.1 | −8.3 |
| beta-sitosterol | −7.3 | −3.4 | −6.5 | −10.6 | −7.6 |
| Phellavin_qt | −7.1 | −3.7 | −6.2 | −9.5 | −7.7 |
| CLR | −7.0 | −3.2 | −6.1 | −9.9 | −8.1 |
| poriferast-5-en-3beta-ol | −7.6 | −3.1 | −6.1 | −9.9 | −7.0 |
| sitosterol | −6.8 | −3.1 | −6.0 | −10.2 | −7.7 |
| Stigmasterol | −7.8 | −3.9 | −5.9 | −9.8 | −8.1 |
| Sitosterol alpha1 | −7.2 | −3.6 | −5.6 | −9.8 | −8.4 |
| Fumarine | −7.4 | −3.9 | −5.5 | −9.5 | −8.9 |
| Chelerythrine | −7.6 | −3.6 | −5.5 | −10.4 | −8.2 |
| Worenine | −7.7 | −4.3 | −5.4 | −10.9 | −9.0 |
| poriferasta-7 | −7.1 | −3.5 | −5.3 | −10.4 | −7.6 |
| epiberberine | −6.8 | −3.8 | −5.1 | −9.4 | −8.6 |
| Cavidine | −6.9 | −3.9 | −4.9 | −8.7 | −8.1 |
| berberine | −7.3 | −3.8 | −4.8 | −9.6 | −8.0 |
| thalifendine | −6.8 | −4.0 | −4.7 | −9.6 | −8.3 |
| (S)-Canadine | −6.7 | −3.8 | −4.7 | −9.1 | −8.1 |
| berberrubine | −6.9 | −3.8 | −4.7 | −9.5 | −7.6 |
| Inophyllum E | −8.6 | −4.4 | −4.2 | −11.7 | −9.7 |
| coptisine | −7.4 | −4.0 | −4.2 | −10.1 | −8.9 |
| Isocorypalmine | −6.5 | −3.9 | −4 | −8.7 | −7.5 |
| palmatine | −6.5 | −3.6 | −3.6 | −8.8 | −7.2 |